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Abstract: 
Background: Surgical site infection (SSI) is one of the most common problem facing 
patients who undergo operative procedures. It remains a common and widespread 
problem contributing to morbidity, mortality, and high cost to the health care system, 
partly attributed to increase in infections due to antimicrobial resistant bacterial 
pathogens. In Palestine there has been very limited data regarding the magnitude of 
SSIs due to antimicrobial resistant pathogens as well as the resistant pattern to 
antibiotics commonly used in the treatment of these infections. P. aeruginosa is an 
aerobic Gram negative, which is considered as one of the most problematic nosocomial 
pathogens especially among postoperative patients. : This study aimed to investigate 
the incidence level of P. aeruginosa in postoperative infection, its antibiotic 
susceptibility pattern and their relatedness using molecular typing technique. 
Methodology: A total of 29 clinical isolates were collected from wounds of 
postoperative patients of different wards at Alia and Alahli hospital. The isolates were 
identified as P. aeruginosa using selective media and API20. The susceptibility pattern 
to different antibiotics was done using disk diffusion method. Molecular 
characterization of the strains were carried out using RAPD. Furthermore a 
retrospective study of a hospital records of the same period of other pathogens causing 
postsurgical wound infection were investigated.  
Results:  
The results showed that the incidence of P. aeruginosa in surgical site infection was 
19.0%. The sensitivity pattern of P. aeruginosa isolated from patients in postoperative 
was mostly sensitive to meropenem, and Imipenem (93%), to amikacin and ceftazidem 
(76.0%), azetroneame 56.6%, piperacillin and cefipem 46.6%. P. aeruginosa was 
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mostly resistant to gentamycin and ciprofloxacin 50 % and 46.6% of isolates were 
resistant to levofloxacin.  
Three RAPD clusters were obtained and were designated as C1 to C7 groups. C1, C3, 
C4  and C6 had identical strains while the rest of the groups had 70% or above similarity 
but not identical. 
The most prevalent pathogen of the retrospective study was S. aureus and the least was 
Enterobacter/Citrobacter freundii.  
In comparison with other postsurgical infection pathogens, P. aeruginosa was ranking 
third.  
Age group and gender had significant correlation with infection, age group in the range 
of 41-50 had higher incidence and males were higher than females. 
Conclusions: 
This study shows the incidence of P. aeruginosa in post-operative wound infections. 
The most causative agents of post operation infections were S. aureus, followed by E. 
coli then P. aeruginosa. 
Molecular techniques used in this study was random amplified polymorphic 
DNA"RAPD-PCR". 
Key words: SSI, P. aeruginosa, RAPD, susceptibility to antibiotic. 
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Chapter One:  
Introduction 
 
Surgical site infection (SSI) means wound infection that occurs somewhere in the 
operative site by both pathogens and body commensals, the infection that happen  
during the operative called a primary wound infection whereas the after  operative 
called secondary wound infection which may be due to subsequent complications 
(Masaadeh, Hani A, Jaran, & S., 2009). surgical site infection classified into two types, 
the first one is incisional SSI which include both superficial incision and deep incisional 
and the second one is organ SSI (Musmar, Ba'ba, & Owais, 2014).  
Surgical site infection is a serious problem despite the advance development in 
technology of surgery and other medical fields (Akinkunmi, Adesunkanmi, & 
Lamikanra, 2014), The incidence of SSI according to CDC was 15.45% in USA, and it 
is considered the third most common cause of  hospital associated infection and account 
for about 25% of all nosocomial infection in USA (Ramesh, Sumathi, Anuradha, 
Venkatesh, & Krishna, 2013 ), It has been shown that postoperative infection leads to 
increase in the mortality and morbidity rates (Afifi & Baghagho, 2010). Mortality rates 
are 2-3 times higher in patients in whom SSI develops contrasted with un-infected 
patients (Bratzler, Houck, & Richards, 2005).  About 77% of the death of surgical 
patients were related to surgical site infection , It also contributes to prolonged 
hospitalization and therapy that ranges from 1 to 16 days (Akinkunmi et al., 2014), the 
cost of therapy increased, according to a report in Denmark showed that the cost of care 
for surgical site infections expend 0.5% of the annual hospital budget (Fry, 2002), and 
in USA the estimated average cost of each SSI is 2,739$ (Abdulsalam et al., 2013). 
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Surgical site infection usually appear from fifth to tenth post operative day, but they 
may appear as early as first post operative day or even years later, according to the 
(CDC); SSI may occur in the first 30 days after surgery or up to one year if implant is 
in place and the infection appears to be related to the operation (Silva & Barbosa, 2012). 
The contamination of surgical site can happen during perioperative period or 
transoperative period while manipulating the tissue in which the entry of 
microorganisms is easy. (Silva & Barbosa, 2012). 
Bacteriological studies have shown that surgical site infection is global problem and 
that the bacteria types existing vary with geographical site whether it is resident on the 
skin, clothing at the site of wound, time between wound and examination (Oguntibeju 
& Rau, 2004). 
The identification of risk factors that lead to SSI, can provide information for 
preventing, controlling, monitoring, and improving the condition to decrease the 
occurring of SSI, and increase the principles of patients safety  (Silva & Barbosa, 2012). 
P. aeruginosa Gram-negative, aerobic rod, free-living bacterium, commonly found in 
soil and water. However, Its adaptability and high intrinsic antibiotic resistance enable 
it to survive in a wide range of other natural and artificial settings, including surfaces 
in medical facilities (LaBauve & Wargo, 2012). 
P. aeruginosa is primarily a nosocomial pathogen.   It is the most common pathogen 
isolated from patients who have been hospitalized longer than 1 week, and it is a 
frequent cause of nosocomial infections. According to the CDC, the overall incidence 
of P. aeruginosa infections in U.S. hospitals averages about 0.4 percent (4 per 1000 
discharges), and the bacterium is the fourth most commonly-isolated nosocomial 
pathogen accounting for about 10 percent of all hospital-acquired infections, 
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Furthermore, the infection is complicated and can be life threatening (Gales, Jones, 
Turnidge, Rennie, & Ramphal, 2001). 
The major virulence factors of P. aeruginosa is: Flagella and pili, these proteinaceous 
appendages function both as motility, adhesions and initiate the inflammatory response 
of the host. Other virulence factors are also secreted by P. aeruginosa and have varying 
effects on the host. Proteases can degrade host complement factors, mucins, and disrupt 
tight junctions between epithelial cells leading to dissemination of the bacteria. Lipases 
and phospholipases can target lipids in the surfactant as well as host cell membranes. 
Pyocyanin, a blue-green pigment, can interfere with host cell electron transport 
pathways and redox cycling (Gellatly & Hancock, 2013), also biofilms formation make 
higher antibiotic tolerance (Lambert, 2002). 
The widespread use of antimicrobial drugs leads to the rise of multidrug resistance 
(MDR), Methicillin resistant Staphylococcus aureus (MRSA), extended-spectrum-β-
lactamases (ESBL). vancomycin resistant enterococci (VRE). The antibacterial 
susceptibility testing of bacterial isolates are effective to determine the appropriate 
therapy for patients (Bhatt et al., 2014). 
P. aeruginosa is an extremely difficult organism to control with antibiotics, all of the 
major classes of antibiotics used to treat P. aeruginosa infections need to cross the cell 
wall to reach their targets, but low permeability of  the cell wall makes it resistant to 
antimicrobial agents, Furthermore, P. aeruginosa causes inactivation and modification 
of antibiotics, another possible mechanism of resistance is induced genetic mutations 
in certain enzymes that are vital to the cell metabolism (Lambert, 2002). 
One of the molecular techniques widely used in strain typing include random amplified 
polymorphic DNA"RAPD-PCR", a method based on the amplification of random DNA 
segments with single primers of arbitrary nucleotide sequence. The main advantage of 
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RAPD-PCR over other molecular genotyping techniques is its simplicity, low cost and 
it does not require any specific sequence information for the target genome (Ho, Phang, 
& Pang, 1995). 
The primer is short (e.g. 10-mer), there is a high probability that the genome contains 
several priming sites close to one another that are in an inverted orientation. The 
technique essentially scans a genome for these small inverted repeats and amplifies 
intervening DNA segments of variable length (Hadrys, Balick, & Schierwater, 1992). 
Aims and Objectives: 
 
1. To determine the incidence of P. aeruginosa from postoperative wound 
infections. 
2. To investigate the antimicrobial susceptibility pattern of the P. aeruginosa  
isolates. 
3. To identify the relatedness of the P. aeruginosa  isolates using RAPD molecular 
typing technique. 
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Chapter Two  
 Literature Review: 
1.2 Surgical site infections 
Studies on the SSI are complicated because of  heterogeneous nature of these infections. 
The prevalence and incidence rates of postoperative wound infections vary widely 
according to procedures used, hospitals, surgeons, patients and geographical locations 
(Chahoud, Kanafani, & Kanj, 2014).   
The incidence of SSIs is determined by both pre-operative and intra-operative risk 
factors. Several factors have been leading to increase SSIs risk, such as: Diabetes, 
smoking, obesity, steroid use, alcohol abuse, and old ages (Chahoud et al., 2014). 
Limited studies in Palestine investigated the postsurgical infection. In a study carried 
out by Adwan et al. about the surgical site infections, found out that 63.3% of isolates 
in postoperative wound infections were E. coli which  was susceptible to Meropenem 
and less resistant to Ceftazidime and Amikacin, also showed multi-drug resistant to the 
commonly prescribed antibiotics such as Nalidixic acid, 
Trimethoprim/Sulfamethoxazole, Tetracycline, Norfloxacin, Ciprofloxacin and 
Kanamycin (Adwan. et al., 2016). 
Another study carried out in Egypt on 121 patients undergoing surgery, showed that the 
incidence rate of SSI was 8.264%, which was remarkably higher compared to two 
previous studies in Egypt that showed 2.7% and 4.02%incidence rate among patients. 
Staphylococcus, Pseudomonas spp. and E. coli were the predominant causative agents  
(Afifi & Baghagho, 2010). 
The incidence of P. aeruginosa in postoperative wound infection was determined at 
four Jordanian hospitals from February to December, 2005; 115 specimens were 
collected, the results showed that  27.8% of isolates were P. aeruginosa, followed by 
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E. coli  (15.6%), S. aureus  (14.7%), Acinetobacter calcoaceticus  (13.0%), Klebsiella 
species (12.1 %), Proteus species  (6.0 %), Citrobacter freundii  (3.4%), Streptococcus 
pyogenes (2.6 %), Enterococcus faecalis  (2.6%). In the same study, it was noticed that 
the occurrence of P. aeruginosa was higher among young groups compared to  other 
groups. The lowest causative agents of postoperation infections were Streptococcus 
pyogenes, and Enterococcus faecalis (Masaadeh et al., 2009). 
The incidence of postoperative wound infection in developing countries is becoming a 
more serious problem. Previous studies in different countries such as Pakistan, India, 
Mali and Ethiopia reported that the infections rates ranges from 11-13%, 9-12%, 10.2% 
and 10.9%, respectively (Abdulsalam et al., 2013).  
Assessment of SSIs from Signs & Symptoms of the wound and associated factors in 
public hospitals at Yemen, during the period of July- September 2012 using random 
sampling method, showed that 34 % suffered from SSIs. In this study, it was concluded 
that the rate of infection among males was 26.47% and among females 73.53% and it 
showed that age above 50 years was a risk factor for SSI. Several factors, such as 
diabetes, obesity, hypertension, heart diseases were also considered to be a risk factors 
(Abdulsalam et al., 2013). 
Prophylactic antibiotic reduces the incidence of wound infection. The appropriate 
choice of antibiotic for prophylaxis should depend on its activity against expected 
bacteria at the specific surgical site. Properly timed accurate dose of preoperative 
antibiotics reduces the incidence of SSI (Elbur, Yousif, Sayed, & Abdel-Rahman, 
2014). 
In 2011, a Palestinian study carried out to investigate the level of adherence to 
guidelines of antibiotic prophylactic use in surgery. The prospective cohort study 
included 400 abdominal, orthopedic, and gynecological operations, which were 
7 
 
performed during the study period. The result showed that none of the hospitals is 
following guidelines for perioperative prophylaxis, with high rate of broad spectrum 
antibiotic use, long duration and inappropriate time of first dose (Musmar et al., 2014). 
In a Nigerian study at 2011, they found that obstetrics ward had  the highest number of 
surgical wound infections  (41.7%), followed by both male orthopaedic and male 
surgical ward (16.7%)  while the female surgical ward had the lowest  (8.3%) (Ekom 
& Edem, 2012). 
2.2 Microbiology 
In most postoperative SSIs, the causative pathogens originate from endogenous flora of 
the patient’s skin, mucous membranes or hollow viscera (Reichman & Greenberg, 
2009). 
When mucous membranes or skin is incised the organisms usually involved are aerobic 
gram-positive cocci such as staphylococci, whereas a gastrointestinal organ is incised 
during an operation, the source of pathogens is usually gram negative bacilli such as  E. 
coli, and gram positive organisms such as enterococci (Reichman & Greenberg, 2009).  
Several studies investigated the postsurgical infection caused by various pathogens and 
showed that Staphylococcus was the most common isolated pathogen in addition to 
several other pathogens such as E. coli, Pseudomonas spp., Klebsiella spp., etc. 
(Bowler, Duerden, & Armstrong, 2001). 
Among the Staphylococci, Staphylococcus aureus is considered the most important 
pathogen and is usually found as a normal flora in the nasopharynx of up to 15 % of the 
population. It can cause exogenous suppuration in wounds. Strains resistant to 
antibiotics such as MRSA can cause epidemics and more severe infection. 
 Staphylococcus epidermidis, was regarded as a commensal but is now recognized as 
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a major threat in prosthetic surgery and in indwelling vascular catheters  (Mangram, 
Horan, Pearson, Silver, & Jarvis, 1999). 
A study was done at a university hospital in Iran, on a surgical patients reported that S. 
aureus to be the commonest bacterial pathogen (43%), followed by Escherichia coli 
(21%), Klebsiella spp. (13%), Pseudomonas spp. (10%) and coagulase negative 
staphylococcus (5%). In the same study, MRSA accounted for a high rate of 78.9% of 
all S. aureus isolates (Khorvash et al., 2008). 
Escherichia coli is another important nosocomial pathogen involved in several 
postsurgical infections (Williams, 2008). In a study carried out by Schnuriger et al. , 
they found that E. coli was the commonest cause of surgical site infection of colonic 
injury accounting for 64.7% (Schnuriger et al., 2010). 
P. aeruginosa is an opportunistic pathogen which is considered as one of the leading 
causes of hospital-acquired infections especially lung, urinary tract and surgical wound 
infection (Iglewski, 1996).  
Several studies have reported the occurrence of P. aeruginosa in postoperative wound 
infections. A study investigated the a postoperative infection of 80 samples found that 
P. aeruginosa was major agent, accounting for  33.3% followed by Staphylococcus 
aureus  (21.7%), Klebsiella spp. (16.7%), Escherichia coli (11.7%), coliform  (6.7%), 
Proteus spp.  (6.7%), Streptococcus pyogenes  (1.7%) and Enterococcus faecalis  
(1.7%) (Oguntibeju & Rau, 2004). Another study carried out in Jordan 2003, on 
caesarean surgeries, P. aeruginosa accounted for 5.3% (Kaplan, Smadi, Al-Taani, & 
El-Qudah, 2003). A Saudi Arabian study conducted at 2016 on postsurgical infected 
patients found that  P. aeuoginosa was the most common isolate accounting for 31.6%, 
followed by Methicillin–Resistant Staphylococcus aureus (21%) and Acinetobacter 
baumannii (17.5%) (El-Ageery & Otibi, 2016). 
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2.3 Pathogenesis 
The risk of development of SSIs depends on several factors such as the dose and 
virulence of the pathogens, and host defense mechanisms. 
Virulence of pathogens depends on their ability to produce toxins and other substances 
that rise their ability to invade the host and causing tissue damage.  
Lipopolysaccharide triggers the release of precursor of coagulant factors and 
inflammatory mediators such as cytokine, which may initiate inflammatory response 
and cause multiple systemic organ failure. Some bacteria produce polysaccharide 
capsule, which inhibits phagocytosis which is a critical host immune response 
following bacterial infection (Gellatly & Hancock, 2013). 
2.4 Risk factors for surgical site infections 
A number of preoperative, perioperative and postoperative factors found to be increase 
the risk of postoperative SSIs. 
Preoperative factors such as patient age, diabetes mellitus, education status, socio-
economic, obesity, hypertension, heart diseases were significantly increased the risk of 
SSI (Afifi & Baghagho, 2010),(Abdulsalam et al., 2013). 
 In a study carried out in USA during the period of February 1991 to July 2002 at 11 
hospitals on 144,485 patients underwent surgery showed that the rate of SSIs was 1.2%. 
Age was a significant risk factor for SSIs. (Kaye et al., 2005).  
Perioperative transfusion of blood or its components is a risk factor for the development 
of postoperative bacterial infection including SSI. According to Amenu et al. the  
women with intra-operative blood loss of more than 1000 ml were more likely to have 
perioperative blood transfusion and had significant association with increased risk of 
SSIs (Amenu, Belachew, & Araya, 2011).  
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Postoperative care including the use of aseptic non-touch technique for changing or 
removing surgical wound dressings and the using of antibiotic decrease the risk of SSIs. 
(Press, 2008). 
 
2.5 Antimicrobial chemotherapy 
Prophylactic Antibiotics 
It has been shown that postoperative infections can be prevented by using appropriate 
prophylactic antibiotics given before surgery (Kirk R.M., 2004), several studies showed 
that’s if antibiotic treatment was not administered it will lead to increase incidence and 
severity of postoperative SSIs (Amenu et al., 2011). Inappropriate use of antibiotics for 
surgical prophylaxis increases both cost and emergence of resistant bacteria, and makes 
the choice of empirical antimicrobial agents more difficult (Goswami et al., 2011). 
Antibiotic prophylaxis should be used only when wound contamination is expected or 
when operations on a contaminated site may lead to bacteremia, also when an implant 
or vascular graft has been inserted, and in valvular heart disease to prevent infective 
endocarditis. Normally in a clean operation, one dose is sufficient. In contaminated 
operations three doses are usually given (Kirk R.M., 2004). 
Antimicrobial susceptibility pattern 
The widespread uses of antimicrobial drugs lead to cause MDR, which is  a condition 
causing organism to resist distinct drugs or chemicals of a variety of structure and 
function targeted , so that Multi-drug resistant (MDR) bacteria are resistant to two or 
more classes of antibiotics, such as, Methicillin resistant Staphylococcus aureus 
(MRSA), extended-spectrum-β-lactamases (ESBL) producing enterobacteria and 
vancomycin resistant enterococci (VRE). These resistant bacteria have become most  
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hospital problems and leaving physician with few therapeutic options, therefor when 
the first choice is not effective they tend to use the other choice of antibiotics which are 
usually less effective toxic, and more expensive (Bhatt et al., 2014). Antibiotic 
resistance can be controlled by  suitable antimicrobial prescribing, new therapy  
alternatives, and continued surveillance (Goswami et al., 2011). 
P. aeruginosa is an example of opportunistic nosocomial pathogen, which cause a wide 
spectrum of infections and leads to morbidity in immunocompromised patients and 
develops resistance to many antibiotics which results in difficult selection of 
appropriate treatment. 
The study of  antibacterial susceptibility patterns of P. aeruginosa are effective to 
determine appropriate  therapy for infected patients (Bhatt et al., 2014). The sensitivity 
pattern of P. aeruginosa isolated from patients in postoperative wound infections was 
studied in four hospitals in Jordan, P. aeruginosa was sensitive to amikacin, 
gentamicin, tobramycin, ciprofloxacin and aztreonam with amikacin showing the 
highest percentage sensitivity (Masaadeh et al., 2009). 
Recently, a study in Palestine showed that the prevalence of pathogens among surgical 
site infections was 56.7%, 30%, 6.7%, 3.3% and 3.3% for E. coli, S. aureus, Klebsiella 
sp., Enterobacter sp., and Acinetobacter sp., respectively. E. coli isolates showed high 
resistance against Nalidixic acid (88.2%), Trimethoprim/ Sulfamethoxazole (76.5%), 
Tetracycline (70.6%), Norfloxacin (64.7%), Ciprofloxacin (58.5%). S. aureus showed 
high resistance against Nalidixic acid (88.9%), Norfloxacin (77.8%), Amoxycillin/ 
clavulanic acid (77.8%), Kanamycin (66.7%) and Ciprofloxacin (55.6%). Methicillin 
resistant S. aureus accounted for 33.3% of all S. aureus isolates. Resistant to 3 or more 
antibiotics were detected in 94.1%  and 77.8% of E. coli and S. aureus isolates, 
respectively (Adwan. et al., 2016). 
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In a study conducted by Garba et al., the sensitivity pattern of P. aeruginosa to various 
antibiotics were as follows: ofloxacin (72%), ceftriazone (54%), cefuroxime (54%) and 
gentamycin (54%), strong resistance to cotrimoxazole, amoxicillin tetracycline and 
augmentin (Garba et al., 2012). 
Another study carried out in two main tertiary care hospitals in Saudi Arabia, showed 
that the antibiotic susceptibility rates among P. aeruginosa  for amikacin, ciprofloxacin 
and cefotaxim were 83.3 %, 75.9% and 70.4% respectively and the resistant rates for 
piperacillin/tazobactum, cefepime and ceftazidime were 38.5 %, 32.4% and 29.6% 
respectively. Approximately 43% of the isolates were found to be sensitive to 
all antibiotics, while 36.1% of them were found to be resistant to more than three 
antibiotics. Only 3.7 % of the isolates were found to be resistant to one antibiotic, while 
8.3% and 9.3% of isolates were found to be sensitive to 2 and 3 of antibiotics, 
respectively (Ahmed, 2016).  
Various literature have documented several risk factors associated with isolation of 
antimicrobial resistant pathogens from patients. In a case control study conducted in 
Denmark to identify possible risk factors for MRSA and methicillin susceptible 
Staphylococcus aureus (MSSA), hospitalization for more than 7 days tended to be 
associated with MRSA (Bocher et al., 2008). 
According to Etok et al., extended spectrum beta-lactamase (ESBL) production was 
seen in 50 out of the 100 Gram-negative isolates. All E. coli isolates and 66.7% of the 
Proteus isolates were ESBL producing. All S. aureus isolates were methicillin resistant 
(Ekom & Edem, 2012). 
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2.6 Prevention of surgical site infections 
 
 
Protection of surgical patients from infection is an essential consideration during the 
preoperative, perioperative and postoperative phases of care. Bacterial infection of 
surgical incisions may results from small stitch abscess to massive tissue necrosis, 
septicemia and even death. Some of the factors that determine surgical site infection 
and its effect  are beyond the control of surgeons, but others can be controlled 
(Oluwatosin, 2005). 
prior the surgery, all the materials must be sterilized; this include any device, needles, 
sutures, dressings, gloves and solutions that may come into touch with the wound and 
exposed tissues. In addition, the surgical team must prepare themselves by scrubbing 
the hands with soap and water and using the antiseptic as required. Head and hair must 
be covered and mask should be worn during the operation. Only the person involved in 
the surgery should contact the sterile equipment (Nichols, 2001).  
After the surgery, the wound is protected from potential contamination by sterile 
dressings. The most effective method is administering antibiotic prophylaxis at the 
appropriate time, (20 min before surgery), if it is  administered too late or too early then 
it will reduces the efficacy of the antibiotic and may increase the risk of SSI. The 
administering of antimicrobial prophylaxis before surgery has been proved to decrease 
greatly the incidence of postoperative infection (Scottish Intercollegiate Guidelines 
Network, 2008). 
A study of 3,836 patients undergoing abdominal, vascular or trauma surgery given a 
single dose of cefuroxime (plus metronidazole for colorectal cases) compared the rate 
of SSI for time intervals between 0 and 2 hours prior to the procedure. The overall SSI 
rate was 4.7% and administration of antibiotic prophylaxis 30–60 minutes pre-incision 
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resulted in the lowest rates of SSI (2.42% for 45–59 minutes and 3.33% for 30–44 
minutes)  (Scottish Intercollegiate Guidelines Network, 2008). 
Skin and Hand Hygiene 
When it comes to preventing SSI, skin antisepsis is the cheapest and simplest way to 
minimize SSI. There are about 100-1000 microbes on the skin and are mostly located 
on corneal layer, if the hands are not disinfected properly after patient contact, the 
microbes will be transferred to the next patient. Antiseptics commonly used for hand 
washing are 4% Chlorhexidine gluconate , hexachlorophane or Povidone-iodine  
(Larson, 1999). 
 
Aseptic in operation room:  
Operation room should be located away from the inpatient area and located on the top 
floor, big enough for free circulation, temperature between 18 and 24º C and humidity 
of about 50 to 55%. 
Cleaning, disinfection and sterilization are the fundamental in ensuring operation room 
asepsis. Formaldehyde fumigation procedure commonly used to sterilize the operating 
room, also daily ultra violet irradiation for 12 -16 hours is a useful procedure (Eredie, 
2008)  
 
 
  
15 
 
Chapter Three 
Materials and Methods 
 
3.1 Study Design 
A cross sectional study was designed to find out the prevalence of P. 
aeruginosa bacteria, which is isolated from patients undergoing surgical operations 
with postoperative wound infection, also to determine the antimicrobial 
susceptibility and molecular characterization of the P. aeruginosa isolates.  
 
3.2 Microbiological identification of P. aeruginosa  
Fifty P. aeruginosa obtained from surgical wounds of patients during Oct. 2015 to 
May 2016 from two hospitals in Hebron (Queen Alia hospital and AL-Ahli 
hospital), Palestine. The isolates were identified at the hospitals laboratories, 
stocked, and stored at Al-Quds University Laboratory at -20 0C, in 50%v/v sterile 
glycerol/LB. Only 29 of the isolates could be revived, purified and subjected to 
further identification. The epidemiological data for the patients in whom P. 
aeruginosa isolates are listed in table 1.  
 
 
 
Enter 
date 
Hospital 
name 
Hospital ward Age Gender Patient 
number 
22/5/2016 Queen Alia Medical ward 66 Male 1 
7/4/2016 Queen Alia Urology ward 57 Male 2 
15/5/2016 Queen Alia Urology ward 74 Male 3 
17/5/2016 Queen Alia ICU ward 81 Male 4 
5/4/2016 Queen Alia Surgical ward 29 Male 5 
10/5/2016 Queen Alia Surgical ward 52 Female 6 
P.  whomin  Table 1. Epidemiological data of patients
obtained from Queen Alia and Al Ahli hospitals. isolates  aeruginosa 
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14/4/2016 Queen Alia Emergency 
ward 
62 Female 7 
1/5/2016 Queen Alia Surgical ward 54 Female 8 
11/4/2016 Queen Alia Kidney 
dialysis ward 
60 Female 9 
11/5/2016 Queen Alia Emergency 
ward 
49 Male 10 
8/3/2016 Queen Alia Medical ward 36 Male 11 
11/3/2016 Queen Alia Surgical ward 41 Male 12 
7/4/2016 Queen Alia Urology ward 45 Female 13 
26/4/2016 Queen Alia Surgical ward 49 Male 14 
3/2/2016 Queen Alia E.N.T ward 21 Male 15 
1/10/2015 Queen Alia Surgical ward 17 Female 16 
17/2/2016 Queen Alia Kidney 
dialysis ward 
36 Male 17 
14/3/2016 Queen Alia E.N.T ward 50 Male 18 
22/3/2016 Queen Alia Urology ward 71 Male 19 
21/3/2016 Queen Alia Surgical ward 13 Male 20 
30/5/2016 Queen Alia Medical ward 57 Female 21 
26/4/2016 Al-Ahli Surgical ward 68 Male 22 
7/10/2015 Al-Ahli Surgical ward 64 Female 23 
20/1/2016 Al-Ahli Surgical ward 63 Male 24 
5/5/2016 Al-Ahli Medical ward 47 Male 25 
15/102015 Al-Ahli Orthopedic 
ward 
42 Male 26 
20/3/2016 Al-Ahli Surgical ward 22 Male 27 
8/5/2016 Al-Ahli Medical ward 97 Male 28 
1/3/2015 Al-Ahli Surgical ward 13 Male 29 
3.3 Gram Stain and Culturing 
 The specimens were subjected to gram staining and cultured at blood agar, MacConkey 
agar and chocolate agar, then the plates were incubated at 37C for 24 hours. The plates were 
read in the following day but extended to 48 hours if there was no bacterial growth within 24 
hours. The primary identification of P. aeruginosa isolates were made based on colony 
appearance, pigmentation, and API 20E, (Noble & Michael, 2002).  
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3.4 Antibiotic Susceptibility Testing 
Antimicrobial susceptibility testing was performed at Al-Quds University Laboratory 
on Muller Hinton agar (Hi Media, Mumbai) media using the disc diffusion method 
according to the Clinical and Laboratory Standards Institute (CLSI) +guidelines (Jean 
B. Patel et al., 2016).  
Antibiotics used in our study were piperacillin (100 μg), ceftazidime (30μg), cefepime 
(30μg), imipenem (10μg), meropenem (10μg), gentamicin (10μg), amikacin (30 μg), 
Levofloxacin (5μg),  aztreonam and ciprofloxacin (5 μg) ( Biomaxima, Polish). 
Antibiotic discs were placed on HMA media inoculated with test P. aeruginosa 
isolates media and incubated at 37°C for 24 hrs. After 24 hours each plate was examined 
and growth zones were measured to the nearest millimeter. 
3.5 Extraction of DNA from P. aeruginosa isolates 
Boiling method was used for DNA extraction, one colony placed into 200μl of ultra-
pure water then boiling for 10 minute on 95 ̊C, finally it was centrifuged at 14.000 rpm 
for 5 minute (Clarke, Millar, & Moore, 2003). 
3.6 RAPD-PCR:  
3.6.1. Selection of Primers  
Two Decamer oligonucleotides were used in this study 5' TGCGCGCGGG 3′ - 
5'GCCCGAGCGG 3′ and 5' ACGGCCGACC 3' – 5' GCTGGGCCGA 3' 
(Mahenthiralingam, Campbell, Foster, Lam, & Speert, 1996). After preliminary 
experiments the 5' TGCGCGCGGG 3′ - 5' GCCCGAGCGG 3′ gave better 
discriminatory power and larger number of bands. 
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3.6.2. PCR Amplification 
PCR reaction was carried out in a total volume of 25 µl as following20 µl AccuPower 
PCR PreMix (Bioneer, Korea), 1µl of template DNA, 1µl   primers (1µM) and 3 µl 
ultra-pure water. PCR was performed using the following protocol: 94°C for 5min, 
followed by 35 cycles of denaturation 94°C for 1min, then Annealing is carried out at 
35 °C for 2 min, and Extension at 72°C for 2min, followed by 72°C for 10 min.  
3.6.3. Agarose Gel Electrophoresis  
Electrophoresis of PCR products was carried out on 1.5% (w/v) agarose gel in 1.0 × 
TAE buffer at 100 V for 90 minute. The gel was stained with ethidium bromide. A 
100bp ladder (Genedirex, Taiwan) was used as a molecular weight standard. Negative 
control and positive control (P. aeruginosa CCUG 17619) was included in the PCR 
reaction. Gels were photographed under UV light and comparison of band patterns were 
analyzed based on UPGMA method using Ward’s Method/ Squared Euclidean Distance by 
SPSS software version 20. 
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Chapter Four 
Results 
 
Of the 264 post-surgical infections collected from the two hospitals 50 (19%) were P. 
aeruginosa and the remaining pathogens were distributed as following: 23.0%, 20%, 
8.7%, 6.8%, 5.7%, for S. aureus, E. coli, Klebsiella spp., Enterococcus spp., 
Acinatobacter spp., respectively. The rest 16% were miscellaneous as shown in table 
2. The majority of P. aeruginosa isolates were obtained from Queen Alia Hospital 30 
(60.0%) while 20 (40.0%) from AL- Ahli Hospital.  
  
 
 
 
 
 
Microorganism 
Number of isolates  
Percentage % Queen Alia Al Ahli  
S. aureus 49 12 23 
E. coli 33 20 20 
P. aeruginosa 30 20 19 
Klebsiella spp. 9 14 8.7 
Enterococcus spp. 12 6 6.8 
Acinetobacter spp. 4 11 5.7 
Proteus 8 4 4.5 
MRSA 12 0 4.5 
Staphylococcus 
epidermidis 
11 0 4.1 
α-hemolytic 
Streptococcus 
6 0 2.3 
Enterobacter spp. 2 0 0.7 
Citrobacter freundii. 2 0 0.7 
Table 2: The frequency and percentage of microorganisms isolated from patients with 
postoperative wound infection in from Queen Alia and AL- Ahli Hospitals.  
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There was a significant correlation between age and rate of infection since the age 
group 41-50 had higher incidence of infection in comparison to other groups with a P 
value 0.020 as shown in table 3. 
Gender also showed a strong correlation since males had higher rate of infection than 
females with a P value of .024 as shown in Fig.1 
                                                 
 
 
 
 
                                                                                                                                       
 
 
 
 
   
 
 
 
 
 
 
 
The sensitivity pattern of P. aeruginosa isolated from patients in postoperative were 
mostly sensitive to Meropenem, and Imipenem (93%), followed by Amikacin and 
Ceftazidem (76.0%), Azetroneame (56.6%), and piperacillin and Cefipem (46.6%). P. 
aeruginosa was resistant to Gentamycin and ciprofloxacin (50%), 46.6% of isolates 
were resistant to Levofloxacinas shown in table 4, Fig. 2 and 3. 
Age group frequency Percent  
0-10 2 4.0 
11-20 2 4.0 
21-30 5 10.0 
31-40 7 14.0 
41-50 14 28.0 
51-60 8 16.0 
61-70 7 14.0 
71-above 5 10.0 
 Total 50 100.0 
Table 3: Percent of postoperative wound infections 
caused by P. aeruginosa according to age group. 
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Antibiotics Number & % Resistant Number & % Sensitive 
Number & % 
Intermediate 
Meropenem (MEM) 2 (6%) 28 (93%) 0 
Impenem (IMP) 2 (6%) 28 (93%) 0 
Amikacin (AK) 5 (16%) 23 (76%) 2 (6%) 
Ceftazedim (CAZ) 2 (6%) 23 (76%) 5 (16%) 
Azetroname (ATM) 2 (6%) 17 (56.6%) 11 (36.6%) 
Levofloxacin (LEV) 14 (46.6%) 15 (50%) 1 (3.3%) 
Cefipem (FEP) 10 (33.3%) 14 (46.6%) 6 (20%) 
Piperacllin (PRL) 10 (33.3%) 14 (46.6%) 6 (20%) 
Ciprofloxacin (CIP) 15 (50%) 14 (46.6%) 1 (3.3%) 
Gentamycin (CN) 15 (50%) 8 (26.6%) 7 (23.3%) 
Male 
Female 
Figure 1. Percent of postoperative wound infections caused by P. aeruginosa  
according to gender. 
Table 4: Antibiotics sensitivity pattern of P. aeruginosa isolates recovered from patients 
with postoperative wound infection from Queen Alia and Al-Ahli Hospitals. 
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RAPD typing. 
Out of the 29 isolates subjected to RAPD, a total of 7 RAPD-PCR clusters (C1-C7) at 
a 70% similarity level. Results of RAPD-PCR profiles are presented in Figures 4, 5, 6, 
7 and 8. These results also showed that P. aeruginosa isolates numbered S16, S19 and 
S2 in C1 are identical, while isolates S13, S14 and S15 in C3 are identical, S3 and S11 
in C4 are identical S6, S1, S10 and S8 in cluster C6 are identical while C2, C5, and C7 
groups were clustered but not identical as shown in Fig. 8. 
6%
6%
16%
6%
6%
46.60%
33.30%
33.30%
50%
50%
0% 10% 20% 30% 40% 50% 60%
Meropenem (MEM)
Impenem (IMP)
Amikacin (AK)
Crftazedim (CAZ)
Azetroname (ATM)
Levofloxacin (LEV)
Cefipem (FEP)
Piperacllin (PRL)
Ciprofloxacin (CIP)
Gentamycin (CN)
%  of Resistant
Antibiotics
93.0%
93.0%
76.0%
76.0%
56.6%
50.0%
46.6%
46.6%
46.6%
26.6%
0% 20% 40% 60% 80% 100%
Meropenem (MEM)
Impenem (IMP)
Amikacin (AK)
Crftazedim (CAZ)
Azetroname (ATM)
Levofloxacin (LEV)
Cefipem (FEP)
Piperacllin (PRL)
Ciprofloxacin (CIP)
Gentamycin (CN)
% of Sensitive
Antibiotics
Figure 2. Antibiotic resistant pattern of P. aeruginosa. 
Figure 3. Antibiotic sensitivity pattern of P. aeruginosa. 
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The size of the amplified DNA fragments ranged from 90 to 2000 bp. All the isolates 
were run at the same PCR reaction to avoid the difficulties in reproducibility of the 
technique.   
 
 
 
 
 
 
                         
 
 
                           
 
 
 
 
 
 
 
 
 
                                                                                                                                                                                            
                                                                                     
 
 
 
 
 
 
                              
 
 
                       
Figure 5 RAPD profile analysis of 9 P. aeruginosa isolates 
recovered from patients with postoperative wound infection 
from Queen Alia hospital.  
M: 100 bp DNA molecular weight marker. 
-ve 
Figure 4 - RAPD profile analysis of 10 P. aeruginosa 
isolates recovered from patients with postoperative wound 
infection from Queen Alia hospital. 
M: 100 bp DNA molecular weight marker.  
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1500 
500 
Figure 7- RAPD profile of 8 P. aeruginosa 
isolates recovered from patients with postoperative 
wound infection from Al-Ahli hospital  
M: 100 bp DNA molecular weight marker. 
+VE: P. aeruginosa positive control (CCUG 
17619). 
 
Figure 6- RAPD profiles of 2 P. 
aeruginosa isolates from Queen Alia 
hospital  
M: 100 bp DNA molecular weight 
marker. 
 
100 
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Figure 8: Dendrogram of 29 clinical P. aeruginosa isolates recovered from surgical site 
infections based on the UPGMA method using Ward’s Method/ Squared Euclidean 
Distance by SPSS software version 20, derived from analysis of the RAPD-PCR-profiles 
at a 70% similarity. 
level. C: Cluster 
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Chapter 5 
DISCUSSION 
A surgical site infection is a postoperative complication that brings about trouble to the 
surgeon, financial burden, extreme discomfort to the patient, and sometimes death. The 
effective management of patients suffering from infection depends upon the 
identification of the types of organisms that cause the diseases and the selection of an 
effective antibiotic against the organism. The wound of surgical site is considered one 
of the major health problems in the world (Garba et al., 2012).  
Most of the SSIs are hospital acquired and vary from hospital to hospital. The incidence 
of P. aeruginosa in surgical site infection is becoming more serious in developing 
countries because of relaxation in general hygienic measures, low quality antiseptic and 
medicinal solutions for treatment (Bertrand, Thouverez, Patry, Balvay, & Talon, 2001). 
Our study showed that the prevalence rate of P. aeruginosa was 19%, among all the 
pathogens isolated from the surgical wound during the study period, ranking third after 
S. aureus and E. coli with prevalence rate of 23% and 20% respectively. Our finding 
was in concordance with a recent study carried out by Murphy et al., which showed that 
P. aeruginosa was isolated from 16% of isolates ranking second and S. aureus was the 
first with 34% (Murphy et al., 2016). 
Other studies have reported P. aeruginosa to be the most prevalent with 29.6%, and 
32% carried out by Ranjan et al., and Anupurba et al. respectively (Ranjan, Ranjan, 
Bansal, & Arora, 2010),(Anupurba, Bhattacharjee, Garg, & Sen, 2006). 
More studies from nearby countries have also reported similar or even higher rate of 
prevalence. In a study done by Masaadeh et al., from Jordan who reported 27.8% 
(Masaadeh et al., 2009), Raafat et al. from Egypt have reported 17.8% (Marwa M. 
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Raafat, 2016), and in a Saudi Arabian study P. aeruginosa was reported to be  31.6%  
(El-Ageery & Otibi, 2016). 
When factors such as age and sex were considered, it was found the P. aeruginosa was 
higher in males (66%) and in patients with age group of 41 – 50 years  28.0% followed 
by 51 – 60 years age group of 16.0%.  This was in agreement with several other studies. 
Jamshaid et al., also reported that P. aeruginosa infections were more common in 
males, and Stephen et al., also reported in their study that male patients had higher 
isolation rates. Regarding age group Stephen et al., found that P. aeruginosa was more 
commonly isolated from patients in the age group 21–30 years (Stephen S. S  et al., 
1990). This may be related to males risk-taking activities at work, In addition, it has 
been suggested that hair growth and shaving interfere with wound dressing adherence, 
which could lead to a higher risk of infection among men who have thicker, coarser 
hair (Cohen et al., 2013). In regard to age group it has been suggested that as people 
advance in age, is considered as important factor for the development of SSIs as an old 
age patients there is low healing rate, low immunity, and presence of underlying 
diseases such as diabetes, hypertension, etc (Khan, P, Rashed, & Banu, 2013) 
P. aeruginosa isolates recovered from patients with postoperative wound infections 
showed higher susceptible to meropenem and impenem, (93.0%), which are usually 
used empirically to treat Pseudomonas infections followed by ceftazidem and amikacin 
(76.0%). Navaneeth et al., in their study, reported 88% susceptibility against both 
imipenem and meropenem, among P. aeruginosa isolates (Navaneeth, Sridaran, Sahay, 
& Belwadi, 2002). Bonfiglio et al., in their study, concluded that meropenem was the 
most active compound against P. aeruginosa isolates, followed by amikacin (Bonfiglio 
et al., 1998). 
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Other study have reported the excellent activity of amikacin against P. aerugonosa 
(Ahmed, 2016).                           
On the other hand, P. aeruginosa was resistant to levofloxacin 46%, ciprofloxacin 50%, 
and gentamicin 50%. Gentamicin is a cheap and easily available drug that is used 
extensively in hospitals, this may be the main reason for the development of resistance 
in bacteria against this drug. 
Bacterial resistance to beta-lactam antibiotics such as piperacillin and azetroneame  is 
primarily due to the production of beta-lactamase of the antibiotics rendering them 
inactive.   
RAPD-PCR generated seven cluster designated as (C1-C7). P. aeruginosa isolates 
numbered S16, S19 and S2 in C1 are identical, while isolates S13, S14 and S15 in C3 
are identical S3 and S11 in C4 are identical S6, S1, S10 and S8 in cluster C6 are 
identical. 
Patterns were considered different when they differed by more than one band (Betancor 
et al., 2004), and the intensity of the band was not consider as polymorphic (Sayed et 
al., 2009). 
There was generally relationship between RAPD-PCR and antibiotic susceptibility of 
the isolates. Strains number S6 and S8 of cluster "C6", RAPD had similar antibiotic 
profile, when looking at the epidemiological data both isolates were from the same ward 
(surgical word), at the same time. In addition, strains number S16 and S19 of pattern 
"C1" share a relationship with the antibiotic susceptibility profile suggesting cross-
infection between patients in the same wards and even between different wards of 
Queen Alia Hospital.  
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CONCLUSIONS 
 
In this study, the incidence of P. aeruginosa ranked third after S. aureus and E. coli. in 
SSIs. The males had higher rate of infection in comparison to females. P. aeruginosa 
isolates recovered from patients with postoperative wound infections showed higher  
susceptible maximum to meropenem and impenem (93%). The rates of resistance of P. 
aeruginosa isolates was 46% for levofloxacin and 50% for each ciprofloxacin and 
gentamicin. P. aeruginosa from surgical wound infections have multi drug resistance 
to a many of the antibiotics used in this study. RAPD-PCR is a useful method for fast 
and inexpensive for investigation of strain relatedness. The results of RAPD and 
antibiotic susceptibility suggest a cross contamination between patients. 
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Appendices 
Bacterial culture media 
Table1: Bacterial culture media used during this study 
Media Manufacture 
Blood agar Himedia (India) 
Muller Hinton agar Himedia (India) 
Macconkey agar Himedia (India) 
Nutrient agar Himedia (India) 
Cetrimide agar Himedia (India) 
 
 
Reagents 
Table2:  Reagents and materials employed in the study 
 
 
  
Reagent Manufacture 
Gram stain reagents Sigma (USA) 
API20e BioMerieux 
 
DNA molecular weight marker (100)bp 
ladder 
Promega (USA) 
Master Mix Promega (USA) 
Primers TIB MOLBIOL (Germany ) 
Antibiotic disks  Himedia( India), Oxoid (UK 
Ethidium bromide   Sigma (USA) 
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Equipment 
Table3: Apparatus and special equipment that were used in the study 
Thermal cycler  
 
 
Eppendorf 
Research pipettes    Eppendorf 
PCR microfuge tube, 0.2 ml  
 
Eppendorf 
Microwave oven  
 
LG 
Hoefer Shortwave UV light Table, (Trans 
illuminator) 
 
Hoefer (USA) 
 
Micro-Centrifuge   
 
Sanyo (UK) 
Electrophoresis set-up  
 
 
 
BioRad (USA) 
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(عصية القيح كتيريا الزائفة الزنجارية لبالحيوية  التوصيف الجزيئي والمضادات
 .المعزولة من العدوى بعد العمليات الجراحية الأزرق) 
  ملحمناجح ياسين  هبهاعداد:  
  حاتم عيدهالدكتور اشراف :  
  ملخص:ال
التهاب العمليات الجراحية هو من المشاكل الأكثر شيوعا للمرضى الذين خضعوا لإجراء العمليات. 
مشكلة واسعة النطاق تساهم في الممراضة والوفيات، وارتفاع تكلفة الرعاية الصحية، ويعزى تعد 
ذلك جزئيا إلى زيادة في عدد الإصابات بسبب مسببات الأمراض البكتيرية المقاومة للمضادات 
ة الحيوية. في فلسطين هناك بيانات محدودة للغاية فيما يتعلق حجم الاصابة بسبب الجراثيم المقاوم
المضادة للميكروبات فضلا عن نمط مقاومة للمضادات الحيوية المستخدمة عادة في علاج هذه 
الالتهابات. الزائفة الزنجارية هي سلبية غرام الهوائية، والتي تعتبر واحدة من مسببات الأمراض 
الهدف المكتسبة داخل المستشفى والأكثر إشكالية خاصة بين المرضى بعد العملية الجراحية. وكان 
من هذه الدراسة إلى معرفة مستوى الإصابة بالزائفة الزنجارية بعد العملية الجراحية، نمطها عند 
 التعرض للمضادات الحيوية والقرابة وذلك باستخدام تقنية الوصف الجزيئي.
العزلات السريرية من جروح المرضى بعد العملية الجراحية من  03المنهجية: تم جمع ما مجموعه 
مختلفة. وقد تم التعرف على العزلات كما الزائفة الزنجارية باستخدام اوساط غذائية خاصة اقسام 
وفحص نمط الحساسية للمضادات الحيوية المختلفة. تم ايضا ايجاد العلاقة  02IPAلنموها و
وبالإضافة إلى ذلك تم الرجوع لسجلات المستشفى  DPARالجزيئية المسببة للاصابة باستخدام 
التي تسبب عدوى لمعرفة الانواع الاخرى من البكتيريا رة جمع عينات الزائفة الزنجارية من نفس فت
 بعد الجراحة.
٪ وكشف 0.91أظهرت النتائج أن معدل الإصابة الزنجارية الزائفة في عدوى موضع الجراحة كان 
مع قيمة  05-14أيضا أن المزيد من العمر هم أكثر أهمية أن يكون للعدوى في الفئة العمرية 
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 ةاحتمالي وكانت زنجارية، وكان الذكور أعلى اصابة من الإناث إلى الزائفة ال020.0احتمالية كان 
 .420.0الإصابة 
كان النمط حساسية الزائفة الزنجارية المعزولة من المرضى في ما بعد الجراحة في الغالب حساسية 
٪) ، 0.67 ) ، وأيضا لأميكاسين وسيفتازيديم (٪39للكل من مضاد ميروبينيم ، وإيميبينيم (
ة معظمها مقاومة ٪ . والزائفة الزنجاري6.64 ٪، بيبيراسيلين و سيفيبيم 6.65 وازيترونيم 
 ) من الليفوفلوكساسين كان مقاومة.٪6.64٪، أيضا (05للجنتاميسين وسيبروفلوكساسين 
) 3، المجموعة (ب) (4وكانت. المجموعة (أ)  DPARوقد تم الحصول على ثلاث مجموعات 
 سلالة ليس لها صلة. 91سلالات. وكانت بقية  4ومجموعة(ج) 
التي تسبب عدوى جروح بعد اجراء العمليات من عزل  نتيجة دراسة مسببات الأمراض الأخرى 
٪، 7.0٪، 3.2٪، 1.4٪، 5.4٪، 5.4٪، 7.5٪، 8.6٪، 7.8٪، 02٪، 0.32بكتيريا  562
, ، على التواليالراكدةية القولونية، الكلبسيلة، شريي٪ للمكورات العنقودية الذهبية ، الإش7.0و 
 % كانت النتاءج متنوعة.61والباقي 
الزائفة الزنجارية في المرتبة تعتبر غيرها من مسببات الأمراض العدوى بعد الجراحة، بالمقارنة مع 
 الثالثة.
